Cypress Sued Over Unapproved Cold Medication

Law360, New York (April 15, 2011, 6:01 PM EDT) -- Generic-drug maker Cypress Pharmaceutical Inc. was socked with a proposed class action Friday in Pennsylvania for allegedly selling a cold, flu and allergy medication that never received approval from the U.S. Food and Drug Administration.

The breach of contract and breach of warranty suit, lodged in the U.S. District Court for the Eastern District of Pennsylvania, said Cypress' over-the-counter Ceron DM syrup — also marketed as Robitussin Cough & Allergy, Rondec DM and Norel DM — was unregulated, potentially unsafe, ineffective and not suitable for consumption....
To view the full article, register now.